bylvay
albireo - odevixibat - cholestasis, intrahepatic - galla og lifrarmeðferð - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 og 5.
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
sevelamercarbonat stada filmuhúðuð tafla 800 mg
stada arzneimittel ag - sevelamerum karbónat - filmuhúðuð tafla - 800 mg
vibeden stungulyf, lausn 1 mg/ml
sandoz a/s* - hydroxocobalaminum hýdróklóríð - stungulyf, lausn - 1 mg/ml
warfarin teva tafla 1 mg
teva b.v.* - warfarinum natríum - tafla - 1 mg
activelle filmuhúðuð tafla 1mg/0,5 mg
novo nordisk a/s* - norethisteronum acetat; estradiolum inn - filmuhúðuð tafla - 1mg/0,5 mg
balance kviðskilunarlausn 1,5 %
fresenius medical care deutschland gmbh - natrii chloridum; calcii chloridum; magnesii chloridum; glucosum; natrii lactas - kviðskilunarlausn - 1,5 %
balance kviðskilunarlausn 2,3 %
fresenius medical care deutschland gmbh - natrii chloridum; calcii chloridum; magnesii chloridum; glucosum; natrii lactas - kviðskilunarlausn - 2,3 %
balance kviðskilunarlausn 4,25 %
fresenius medical care deutschland gmbh - natrii chloridum; calcii chloridum; magnesii chloridum; glucosum; natrii lactas - kviðskilunarlausn - 4,25 %
centyl með kaliumklorid filmuhúðuð tafla 2,5 mg+573 mg
karo pharma ab* - bendroflumethiazidum inn; kalii chloridum - filmuhúðuð tafla - 2,5 mg+573 mg